Prognostic factors and 5-year overall survival in older adults (≥60 years) with Hodgkin lymphoma in Latin America: A multicenter cohort study
Year: 2025
Type: conference-abstract
Abstract: Background: Data on outcomes and prognostic factors in older adults with Hodgkin lymphoma (HL) from Latin America remain scarce. We aimed to characterize overall survival (OS) and identify clinical predictors of 5-year OS in this population. Methods: We analyzed a multicenter cohort of 241 HL patients, treated with ABVD regimen, aged ≥60 years from Latin America. Clinical, laboratory, and treatment variables were harmonized and cleaned for analysis. Five-year OS was estimated using Kaplan-Meier methods. Univariate Cox regression models tested associations between OS and covariates including age, Ann Arbor stage, lymphocyte count, hemoglobin, and PET response. Variables significant in univariate analyses and clinically relevant were included in a multivariable Cox proportional hazards model. Results: Median age was 68 years (range 60–88), with 61% males. The 5-year OS was 65.2% (95% CI: 58.0–73.3%). In univariate analysis, increasing age (HR per year 1.06, p=0.0018), advanced Ann Arbor stage, lymphopenia (<600/mm³ or <8%; HR=0.43, p=0.007), and anemia (Hb <10 g/dL; HR=0.40, p=0.001) were significantly associated with worse OS. PET response was not significantly associated with OS. In the multivariable model (n=154, 38 events), older age (HR 1.08 per year, p=0.0007), advanced Ann Arbor stage (notably stages IIA, IIIA, IIIB; p<0.05), and lymphopenia (HR 0.39, p=0.023) remained independent predictors of inferior 5-year OS. Hemoglobin was not independently significant after adjustment. Conclusions: Older age, advanced disease stage, and low lymphocyte count independently predict poorer survival in older Latin American patients with HL. These factors should be incorporated into risk stratification and management decisions to improve outcomes. Further research is needed to optimize therapies tailored for this population. Keywords: Hodgkin lymphoma, elderly, Latin America, survival, prognostic factors
Source: Blood
Authors: Amy Alvarenga Tanii, Alana von Glasenapp, Sofía Rivarola, German Stemmelin, Ana Oliver, Victoria Irigoin, Virginia Lema Spinelli, Maria Enciso Arrua, Julio Fernández-Águila, Rosa Rios Jimenez, Fernando Warley, Maria Orlova, Jule Vasquez, miguel Nicolas lopez Caceres, Alfredo Quiroz, Denisse Castro, Marialejandra Torres Viera, Henry Quintero, Luis Mario Villela Martinez, Javier Retamales, Bryan Valcarcel, Brady Beltran, Jorge Castillo, Luis Malpica
Institutions: IPS Central, Hospital Británico de Buenos Aires, Hospital Británico, Hermanos Ameijeiras Hospital, Hospital Italiano de Buenos Aires, Instituto Nacional de Enfermedades Neoplásicas, Clínica Alemana, Hospital Nacional Edgardo Rebagliati Martins, Universidad Central de Venezuela, Asociación Colombiana de Hematología y Oncología, The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4417006914
Cites:
Cited by:
Related to: